NCT02911415View on ClinicalTrials.gov

Open Study of the Duration of Immunity After Vaccination With GamEvac-Combi

CompletedOBSERVATIONAL
Enrollment

60

Participants

Timeline

Start Date

October 31, 2016

Primary Completion Date

December 25, 2017

Study Completion Date

December 25, 2017

Conditions
Ebola Hemorrhagic Fever
Interventions
PROCEDURE

blood sampling collection

It is an observational study; no interventions are planned in the course of common clinical practices during the study period; investigated therapeutic agents or special methods of examination will not be used in the study, except the blood sampling procedure and clinical observation specified in this Protocol.

Trial Locations (1)

194044

"Federal state budget military educational institution of higher education Military medical Academy named after S. M. Kirov Ministry of defense of the Russian Federation", Saint Petersburg

All Listed Sponsors
lead

Gamaleya Research Institute of Epidemiology and Microbiology, Health Ministry of the Russian Federation

OTHER

NCT02911415 - Open Study of the Duration of Immunity After Vaccination With GamEvac-Combi | Biotech Hunter | Biotech Hunter